首页> 外文期刊>Journal of cataract and refractive surgery >Management of myopic astigmatism with phakic intraocular lens implantation.
【24h】

Management of myopic astigmatism with phakic intraocular lens implantation.

机译:有晶状体人工晶状体植入术治疗近视散光。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A 48-year-old woman presented with a manifest refraction of -9.25 -2.25 x 98 that resulted in a best corrected visual acuity (BCVA) of 20/20(-2) in the right eye. She was contact lens intolerant but was not a good candidate for laser in situ keratomileusis because of a thin cornea. A phakic posterior chamber intraocular lens (IOL) with a toric optic was implanted with no operative complications. One day after surgery, the uncorrected visual acuity (UCVA) was 20/15. Five months postoperatively, the UCVA in the operated eye was 20/15 with a manifest refraction of +0.25 -0.25 x 60 and a BCVA of 20/15. No changes to the crystalline lens or anterior lens capsule were seen. This is the first report of implantation of a toric phakic IOL in North America.
机译:一位48岁的女性表现出-9.25 -2.25 x 98的明显屈光度,导致右眼的最佳矫正视力(BCVA)为20/20(-2)。她对角膜接触镜不耐受,但由于角膜较薄,因此不是激光原位角膜磨镶术的理想人选。植入有复曲面的有晶状体后房型人工晶体(IOL),无手术并发症。手术后一天,未矫正视力(UCVA)为20/15。术后五个月,手术眼的UCVA为20/15,屈光度为+0.25 -0.25 x 60,BCVA为20/15。没有观察到晶状体或前晶状体囊的变化。这是在北美地区植入复曲面有晶状体人工晶体的首次报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号